Pharma Search Engine Marketing - Bounce Rates: Did the FDA Warning Letters on Paid Search Have An Impact? Ian Orekondy
by SearchandSocialMedia.com on Jan 01, 2010
- 1,868 views
Pharma Search Engine Marketing: ...
Pharma Search Engine Marketing:
In April of 2009, the FDA's DDMAC issued 48 Warning Letters to 14 pharmaceutical companies regarding their use of paid search (SEM) advertising.
The three issues that were cited as reasons for identifying certain pharma paid search text ads as non-compliant were:
1) Omission of Risk Information (the End of the “One-Click” rule)
2) Failure to Use Required Established Name
3) Inadequate Communication of Indication
Almost all major pharma SEM advertisers paused their campaigns and revamped their text ads to comply with the FDA guidance, resulting in two main types of ads:
1) Branded Reminder Ads
2) Unbranded Claim Ads
How Did The FDA Warning Letters And Pharma Advertisers' Shifting Campaign Strategies Impact Website Bounce Rates?
Accessibility
Categories
Tags
More...Upload Details
Uploaded via SlideShare as Microsoft PowerPoint
Usage Rights
© All Rights Reserved
Statistics
- Favorites
- 0
- Downloads
- 35
- Comments
- 1
- Embed Views
- Views on SlideShare
- 1,859
- Total Views
- 1,868
http://pharmasearchsocialmobile.posterous.com/pharma-bounce-rate-series-part-three-5-ways-t 2 years ago Reply